Researcher
Yves Debaveye
- Disciplines:Anaesthesiology, Intensive care and emergency medicine
Affiliations
- Laboratory of Intensive Care Medicine (Division)
Member
From1 Oct 2002 → Today
Projects
1 - 6 of 6
- Optimizing Antibacterial Dosing in Special Patient PopulationsFrom24 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- ANTIBACTERIAL DOSING IN SPECIAL PATIENT POPULATIONS WITH SEVERE BACTERIAL INFECTIONS: A PATIENT-ORIENTED AND COVARIATE-DRIVEN APPROACHFrom1 Oct 2016 → 30 Sep 2021Funding: BOF - Doctoral projects, BOF - doctoral mandates
Publications
61 - 70 of 92
- The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT(2019)
Authors: Greet De Vlieger, Ilse Vanhorebeek, Michael Casaer, Yves Debaveye, Greet Hermans, Philippe Meersseman, Greet Van den Berghe, Catherine Ingels
- Successful use of VV-ECMO in a pregnant patient with severe ARDS(2019)
Authors: Yves Debaveye, Sandra Verelst, Steffen Rex
Pages: 111 - 112 - Impact of supplemental parenteral nutrition early during critical illness on invasive fungal infections: a secondary analysis of the EPaNIC randomized controlled trial.(2019)
Authors: Greet De Vlieger, Catherine Ingels, Yves Debaveye, Ilse Vanhorebeek, Joost Wauters, Alexander Wilmer, Michael Casaer, Greet Van den Berghe
Pages: 359 - 364 - ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.(2018)
Authors: Bram Peeters, Philippe Meersseman, Yves Debaveye, Lies Langouche, Greet Van den Berghe
Pages: 2048 - 2058 - Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review(2018)
Authors: Steffen Fieuws, Ina Jochmans, Yves Debaveye, Johan Maertens, Peter Vandenberghe, Wim Laleman, Schalk Van der Merwe, Chris Verslype, David Cassiman, Patrick Ferdinande, et al.
Pages: 3007 - 3020 - Adrenocortical function during prolonged critical illness and beyond: a prospective observational study(2018)
Authors: Bram Peeters, Philippe Meersseman, Yves Debaveye, Jaak Billen, Pieter Vermeersch, Lies Langouche, Greet Van den Berghe
Pages: 1720 - 1729 - Early versus Late Parenteral Nutrition in Critically Ill Children(2016)
Authors: Tom Fivez, Ilse Vanhorebeek, Yves Debaveye, Dirk Vlasselaers, Michael Casaer, Greet Van den Berghe
Pages: 1111 - 22 - Pathophysiology and management of pituitary disorders in the critically ill(2016)
Authors: Yves Debaveye, Greet Van den Berghe
Pages: 1246 - 1250 - Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU(2015)
Authors: Greet Hermans, Helena Van Mechelen, Beatrix Clerckx, Philippe Meersseman, Yves Debaveye, Michael Casaer, Alexander Wilmer, Ilse Vanhorebeek, Rik Gosselink, Greet Van den Berghe
Pages: 2138 - 2148 - Fluid challenges in intensive care: the FENICE study: A global inception cohort study(2015)
Authors: Yves Debaveye
Pages: 1529 - 37